Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Roche-Tochter Chugai beantragt Zulassungserweiterung für Krebsmittel Alecensa | 25 | cash | ||
19.06. | NEC Corporation: NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment | 318 | JCN Newswire | - Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% -TOKYO, June 18, 2025 - (JCN Newswire) - NEC Corporation (NEC; TSE: 6701), in collaboration... ► Artikel lesen | |
19.05. | Rani Therapeutics erforscht orale Verabreichung von Chugai-Medikamenten | 8 | Investing.com Deutsch | ||
CHUGAI PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
19.05. | Rani Therapeutics explores oral delivery of Chugai's drugs | 4 | Investing.com | ||
19.05. | Rani Therapeutics Announces Research Agreement with Chugai | 266 | GlobeNewswire (Europe) | - Research agreement is evaluating feasibility of applying Rani's oral delivery technology to Chugai's antibodies against undisclosed targets - SAN JOSE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Rani... ► Artikel lesen | |
18.04. | Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai | 16 | Japan Times | ||
09.01. | Araris Biotech kooperiert mit Chugai Pharmaceutical | 5 | punkt4.info | ||
08.01. | Chugai and Araris enter $780m ADC research collaboration | 4 | Pharmaceutical Technology | ||
30.07.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.07.2024 | 962 | Xetra Newsboard | The following instruments on XETRA do have their first trading 30.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.07.2024
Aktien
1 US1712691039 Chugai Pharmaceutical... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TRULIEVE CANNABIS | 3,040 | +0,93 % | Trulieve Cannabis Corp: Trulieve to open dispensary in Florida | ||
WEST PHARMACEUTICAL SERVICES | 186,30 | -0,40 % | Barclays initiates West Pharmaceutical stock with equalweight rating | ||
SHIONOGI | 15,100 | 0,00 % | Shionogi-Aktie unter Druck: Kurs fällt um 4,76 Prozent (14,00 €) | Die Aktie von Shionogi zählt heute zu den großen Verlierern am Aktienmarkt. Das Wertpapier verbilligt sich am Montag deutlich. Ein Verlust von 4,76 Prozent zeigt die Kurstafel für das Wertpapier von... ► Artikel lesen | |
KALA BIO | 4,074 | +3,19 % | KALA BIO, Inc.: KALA BIO Announces Chief Executive Officer Transition | ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative... ► Artikel lesen | |
CHARLOTTES WEB | 0,062 | +0,81 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports Shareholder Meeting Voting Results | LOUISEVILLE, Colo., June 13, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce... ► Artikel lesen | |
BEXIMCO | 0,430 | +4,37 % | Beximco Pharma awaits High Court decision on BSEC director order | ||
LUYE PHARMA | 0,374 | +1,63 % | LUYE PHARMA (02186): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2025 | ||
GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc. - 15-12G, Securities registration termination | ||
PERCHERON THERAPEUTICS | 0,004 | 0,00 % | XFRA AWY0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPERCHERON THERAPEUTICS... ► Artikel lesen | |
MIRUM PHARMACEUTICALS | 43,000 | 0,00 % | Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates | FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today provided its preliminary and unaudited estimates for full-year 2024 net product sales, year-end cash balance... ► Artikel lesen | |
AYURCANN | 0,013 | 0,00 % | Ayurcann Holdings Corp.: Ayurcann Reports Another Record Sales Growth In Q2 2025 Of $13,363,509 | Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company") is excited to announce record-breaking financial results for the... ► Artikel lesen | |
AVANT BRANDS | 0,452 | 0,00 % | Avant Brands Inc.: Avant Brands Strengthens Global Position with Strategic International Supply Agreements and 30+ New Product Rollout Across Canadian Provinces | KELOWNA, BC / ACCESS Newswire / June 23, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products,... ► Artikel lesen | |
EVEREST MEDICINES | 5,950 | 0,00 % | EVEREST MED (01952): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 27 JUNE 2025 | ||
KALBE FARMA | 0,073 | +0,69 % | KLBF subsidiary partners with GE HealthCare to produce local CT scans: KLBF inaugurates new factory ... | ||
KOBAYASHI PHARMACEUTICAL | 31,200 | 0,00 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen |